ADVFN US – Market Content Editor

Kraig Biocraft Laboratories, Inc. (USOTC:KBLB) has launched a new research and development programme aimed at improving the production and performance of recombinant spider silk through targeted dietary supplements for its genetically engineered silkworms. The initiative focuses on supplying specific nutritional components intended to support the production of spider silk proteins, complementing the company’s existing genetic…

Roche (USOTC:RHHBY) has received 510(k) clearance from the US Food and Drug Administration (FDA) for its cobas eplex respiratory pathogen panel 3 (RP3), a diagnostic test designed to detect up to 19 respiratory viruses and bacteria from a single patient sample. The new panel allows laboratories to select from five testing configurations based on local…

Medical Care Technologies Inc. (USOTC:MDCE) has reported updated internal testing results for its MDCE Melanoma Scan Beta platform, with an expanded dataset of human-submitted photographs showing improvements in image usability and body-map registration. The company reported an image-quality pass rate of 86%, successful body-map registration of 89% and a 91% alignment rate for sequential images…

Artificial Intelligence Technology Solutions, Inc. (USOTC:AITX) has launched a new promotional campaign through its wholly owned subsidiary, Robotic Assistance Devices (RAD), aimed at attracting additional security service providers and remote monitoring companies to its SARA artificial intelligence platform. The initiative, introduced on LinkedIn under the #OpenToWork theme, presents SARA as an AI security professional seeking…

INOVIO (NASDAQ:INO) has received accelerated approval from the US Food and Drug Administration (FDA) for VOCERYQ, a DNA-based immunotherapy designed to reduce the frequency of surgery in adults with recurrent respiratory papillomatosis (RRP), a rare disease associated with human papillomavirus (HPV) infection. The treatment, previously known as INO-3107, targets HPV-6 and HPV-11 and represents the…

Baird Medical Investment Holdings Limited (NASDAQ:BDMD) has entered into a strategic distribution agreement with China Resources Pharmaceutical Commercial Group Medical Devices to expand access to its microwave ablation technology across 19 markets in China. The agreement, signed through Baird Medical’s Chinese subsidiary Nanjing Changcheng Medical Equipment Company Limited, appoints China Resources Medical Devices as the…

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) has filed for Chapter 11 bankruptcy protection and entered into a restructuring agreement that provides for a proposed merger with Ayrmid Ltd., as the pharmaceutical company seeks to reorganise its business while maintaining operations and advancing its cancer treatment programmes. The company has secured commitments for up to $55 million in…

Bright Minds Biosciences Inc. (NASDAQ:DRUG) has received notification from the US Food and Drug Administration (FDA) that its investigational new drug application for BMB-101 in developmental and epileptic encephalopathies (DEEs) has been placed on a partial clinical hold. The regulatory decision affects the company’s proposed US Phase 2 trial, designated BMB-101-105, which is intended to…

Callan JMB, Inc. (NASDAQ: CJMB) has received a complete QuickStrip oral thin-film production line from Rapid Dose Therapeutics Corp., marking a step towards establishing domestic pharmaceutical manufacturing operations at its facility in Texas. The healthcare logistics and critical infrastructure company expects the new manufacturing platform to generate up to $15 million in revenue during its…